Kempf; Dale J.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Kempf; Dale J..The latest application filed is for "treatment of filarial diseases".
Company Profile
1.62.53
- Kempf; Dale J. - North Chicago IL
- Kempf; Dale J. - Libertyville IL
- Kempf; Dale J. - Lake Villa IL
- Kempf; Dale J. - Gurnee
Patent Activity
| Patent | Date |
|---|---|
| Treatment of filarial diseases Grant 10,238,677 - Von Geldern , et al. | 2019-03-26 |
| Tylosin A analogs and derivatives Grant 10,072,040 - von Geldern , et al. September 11, 2 | 2018-09-11 |
| Treatment Of Filarial Diseases App 20170368088 - VON GELDERN; Thomas W. ; et al. | 2017-12-28 |
| Tylosin A Analogs And Derivatives App 20160200757 - von Geldern; Thomas W. ; et al. | 2016-07-14 |
| Macrocyclic hepatitis C serine protease inhibitors Grant 9,309,279 - Ku , et al. April 12, 2 | 2016-04-12 |
| Tylosin A Analogs And Derivatives App 20150259374 - von Geldern; Thomas W. ; et al. | 2015-09-17 |
| Compositions and methods of use of ritonavir for treating HCV Grant 8,901,157 - Kempf , et al. December 2, 2 | 2014-12-02 |
| Cytochrome P450 Oxidase Inhibitors And Uses Thereof App 20140243340 - Klein; Larry L. ; et al. | 2014-08-28 |
| HIV Protease Inhibiting Compounds App 20140194349 - DeGoey; David A. ; et al. | 2014-07-10 |
| Compounds that are useful for improving pharmacokinetics Grant 8,741,938 - Kempf , et al. June 3, 2 | 2014-06-03 |
| Macrocyclic Hepatitis C Serine Protease Inhibitors App 20140148573 - Ku; Yiyin ; et al. | 2014-05-29 |
| HIV protease inhibiting compounds Grant 8,653,141 - Flentge , et al. February 18, 2 | 2014-02-18 |
| Macrocyclic hepatitis C serine protease inhibitors Grant 8,642,538 - Ku , et al. February 4, 2 | 2014-02-04 |
| Novel Compounds That Are Useful For Improving Pharmacokinetics App 20130317071 - Kempf; Dale J. ; et al. | 2013-11-28 |
| Compounds that are useful for improving pharmacokinetics Grant 8,524,753 - Kempf , et al. September 3, 2 | 2013-09-03 |
| Cytochrome P450 Oxidase Inhibitors And Uses Thereof App 20130131085 - Klein; Larry L. ; et al. | 2013-05-23 |
| Prodrugs of HIV protease inhibitors Grant 8,426,388 - DeGoey , et al. April 23, 2 | 2013-04-23 |
| Macrocyclic hepatitis C serine protease inhibitors Grant 8,420,596 - Ku , et al. April 16, 2 | 2013-04-16 |
| Hiv Protease Inhibiting Compounds App 20130023463 - Flentge; Charles A. ; et al. | 2013-01-24 |
| Anti-viral compounds Grant 8,338,605 - Rockway , et al. December 25, 2 | 2012-12-25 |
| Cytochrome P450 Oxidase Inhibitors And Uses Thereof App 20120309762 - Klein; Larry L. ; et al. | 2012-12-06 |
| Macrocyclic Hepatitis C Serine Protease Inhibitors App 20120196792 - Ku; Yiyin ; et al. | 2012-08-02 |
| Anti-viral compounds Grant 8,232,246 - McDaniel , et al. July 31, 2 | 2012-07-31 |
| Novel Compounds That Are Useful For Improving Pharmacokinetics App 20120184559 - Kempf; Dale J. ; et al. | 2012-07-19 |
| HIV protease inhibiting compounds Grant 8,193,227 - Flentge , et al. June 5, 2 | 2012-06-05 |
| Cytochrome P450 Oxidase Inhibitors And Uses Thereof App 20120083490 - Klein; Larry L. ; et al. | 2012-04-05 |
| Compounds that are useful for improving pharmacokinetics Grant 8,133,892 - Kempf March 13, 2 | 2012-03-13 |
| Retroviral protease inhibiting compounds Grant 7,968,707 - Sham , et al. June 28, 2 | 2011-06-28 |
| Anti-infective agents Grant 7,951,800 - Wagner , et al. May 31, 2 | 2011-05-31 |
| Compositions And Methods Of Use Of Ritonavir For Treating Hcv App 20110091423 - Kempf; Dale J. ; et al. | 2011-04-21 |
| Anti-viral compounds Grant 7,915,411 - Betebenner , et al. March 29, 2 | 2011-03-29 |
| Anti-viral compounds Grant 7,910,595 - Betebenner , et al. March 22, 2 | 2011-03-22 |
| Anti-infective agents Grant 7,902,203 - Pratt , et al. March 8, 2 | 2011-03-08 |
| HIV protease inhibiting compounds App 20110003827 - Flentge; Charles A. ; et al. | 2011-01-06 |
| HIV protease inhibiting compounds Grant 7,834,043 - DeGoey , et al. November 16, 2 | 2010-11-16 |
| Prodrugs Of Hiv Protease Inhibitors App 20100286032 - DeGoey; David A. ; et al. | 2010-11-11 |
| Novel Compounds That Are Useful For Improving Pharmacokinetics App 20100280248 - Kempf; Dale J. | 2010-11-04 |
| Method for Treating a Disease, Disorder or Adverse Effect Caused by an Elevated Serum Concentration of an UGT1A1 Substrate App 20100261731 - Kempf; Dale J. ; et al. | 2010-10-14 |
| Anti-Viral Compounds App 20100256139 - Rockway; Todd W. ; et al. | 2010-10-07 |
| HIV Protease Inhibiting Compounds App 20100249181 - DeGoey; David A. ; et al. | 2010-09-30 |
| Compounds that are useful for improving pharmacokinetics Grant 7,786,153 - Kempf , et al. August 31, 2 | 2010-08-31 |
| Anti-viral compounds Grant 7,763,731 - Rockway , et al. July 27, 2 | 2010-07-27 |
| Anti-viral Compounds App 20100168384 - McDaniel; Keith F. ; et al. | 2010-07-01 |
| Macrocyclic hepatitis C serine protease inhibitors App 20100144608 - Ku; Yiyin ; et al. | 2010-06-10 |
| Prodrugs of HIV protease inhibitors Grant 7,718,633 - DeGoey , et al. May 18, 2 | 2010-05-18 |
| Anti-Infective Agents App 20100120753 - Wagner; Rolf ; et al. | 2010-05-13 |
| HIV protease inhibiting compounds Grant 7,696,226 - Randolph , et al. April 13, 2 | 2010-04-13 |
| Anti-infective agents Grant 7,662,958 - Wagner , et al. February 16, 2 | 2010-02-16 |
| Method for treating a disease, disorder or adverse effect caused by an elevated serum concentration of an UGT1A1 substrate Grant 7,547,678 - Kempf , et al. June 16, 2 | 2009-06-16 |
| Anti-infective Agents App 20080214528 - Wagner; Rolf ; et al. | 2008-09-04 |
| Cytochrome P450 Oxidase Inhibitors and Uses Thereof App 20080161246 - Klein; Larry L. ; et al. | 2008-07-03 |
| Retroviral Protease Inhibiting Compounds App 20080139811 - Sham; Hing Leung ; et al. | 2008-06-12 |
| Method for treating a disease, disorder or adverse effect caused by an elevated serum concentration of an ugtiai substrate App 20080138315 - Kempf; Dale J. ; et al. | 2008-06-12 |
| Method for treating a disease, disorder or adverse effect caused by an elevated serum concentration of an UGT1A1 substrate Grant 7,320,961 - Kempf , et al. January 22, 2 | 2008-01-22 |
| Prodrugs of HIV protease inhibitors App 20070270383 - DeGoey; David A. ; et al. | 2007-11-22 |
| Anti-viral Compounds App 20070232645 - Rockway; Todd W. ; et al. | 2007-10-04 |
| Anti-viral Compounds App 20070232627 - Betebenner; David A. ; et al. | 2007-10-04 |
| Compositons And Methods Of Use Of Ritonavir For Treating Hcv App 20070207122 - Kempf; Dale J. ; et al. | 2007-09-06 |
| Anti-viral Compounds App 20070197558 - Betebenner; David A. ; et al. | 2007-08-23 |
| Novel compounds that are useful for improving pharmacokinetics App 20060199851 - Kempf; Dale J. ; et al. | 2006-09-07 |
| HIV protease inhibiting compounds App 20050159469 - Randolph, John T. ; et al. | 2005-07-21 |
| HIV protease inhibiting compounds App 20050148623 - DeGoey, David A. ; et al. | 2005-07-07 |
| HIV protease inhibiting compounds App 20050131042 - Flentge, Charles A. ; et al. | 2005-06-16 |
| HIV protease inhibiting compounds App 20050131017 - DeGoey, David A. ; et al. | 2005-06-16 |
| Anti-infective agents App 20050075331 - Pratt, John K. ; et al. | 2005-04-07 |
| Inhibitors of neuraminidases Grant 6,831,096 - Maring , et al. December 14, 2 | 2004-12-14 |
| Method for treating a disease, disorder or adverse effect caused by an elevated serum concentration of an UGT1A1 substrate App 20040242509 - Kempf, Dale J. ; et al. | 2004-12-02 |
| Method for treating a disease, disorder or adverse effect caused by an elevated serum concentration of an UGT1A1 substrate App 20040192624 - Kempf, Dale J. ; et al. | 2004-09-30 |
| Anti-infective agents App 20040167123 - Pratt, John K. ; et al. | 2004-08-26 |
| Anti-infective agents App 20040162285 - Pratt, John K. ; et al. | 2004-08-19 |
| Inhibitors of neuraminidases App 20040097471 - Maring, Clarence J. ; et al. | 2004-05-20 |
| Anti-infective agents App 20040097492 - Pratt, John K. ; et al. | 2004-05-20 |
| Anti-infective agents App 20040087577 - Pratt, John K. ; et al. | 2004-05-06 |
| Method for improving pharmacokinetics Grant 6,703,403 - Norbeck , et al. March 9, 2 | 2004-03-09 |
| Retroviral protease inhibiting compounds Grant 6,667,404 - Kempf , et al. December 23, 2 | 2003-12-23 |
| Retroviral protease inhibiting compounds App 20030195362 - Kempf, Dale J. ; et al. | 2003-10-16 |
| Retroviral protease inhibiting compounds App 20030100755 - Sham, Hing Leung ; et al. | 2003-05-29 |
| Compositions and methods for enhancing the bioavailability of pharmaceutical agents App 20020198160 - Everitt, Elizabeth A. ; et al. | 2002-12-26 |
| Retroviral protease inhibiting compounds Grant 6,472,529 - Sham , et al. October 29, 2 | 2002-10-29 |
| Inhibitors of neuraminidases Grant 6,455,571 - Maring , et al. September 24, 2 | 2002-09-24 |
| Method for improving pharmacokinetics App 20020039998 - Norbeck, Daniel W. ; et al. | 2002-04-04 |
| Retroviral protease inhibiting compounds App 20020004503 - Sham, Hing Leung ; et al. | 2002-01-10 |
| Retroviral protease inhibiting compounds Grant 6,284,767 - Sham , et al. September 4, 2 | 2001-09-04 |
| Retroviral protease inhibiting compounds App 20010008892 - Chen, Xiaoqi ; et al. | 2001-07-19 |
| Method for improving pharmacokinetics Grant 6,037,157 - Norbeck , et al. March 14, 2 | 2000-03-14 |
| Retroviral protease inhibiting compounds Grant 6,017,928 - Kempf , et al. January 25, 2 | 2000-01-25 |
| Retroviral protease inhibiting compounds Grant 5,674,882 - Kempf , et al. October 7, 1 | 1997-10-07 |
| Retroviral protease inhibiting compounds Grant 5,670,675 - Kempf , et al. September 23, 1 | 1997-09-23 |
| Retroviral protease inhibiting compounds Grant 5,648,497 - Kempf , et al. July 15, 1 | 1997-07-15 |
| Retroviral protease inhibiting compounds Grant 5,635,523 - Kempf , et al. June 3, 1 | 1997-06-03 |
| Retroviral protease inhibiting compounds Grant 5,625,072 - Kempf , et al. April 29, 1 | 1997-04-29 |
| Retroviral protease inhibiting compounds Grant 5,621,109 - Norbeck , et al. April 15, 1 | 1997-04-15 |
| Retroviral protease inhibiting compounds Grant 5,616,720 - Kempf , et al. April 1, 1 | 1997-04-01 |
| Retroviral protease inhibiting compounds Grant 5,597,927 - Kempf , et al. January 28, 1 | 1997-01-28 |
| Retroviral protease inhibiting compounds Grant 5,591,860 - Kempf , et al. January 7, 1 | 1997-01-07 |
| Retroviral protease inhibiting compounds Grant 5,580,984 - Kempf , et al. December 3, 1 | 1996-12-03 |
| Retroviral protease inhibiting compounds Grant 5,545,750 - Kempf , et al. August 13, 1 | 1996-08-13 |
| Retroviral protease inhibiting compounds Grant 5,541,334 - Kempf , et al. July 30, 1 | 1996-07-30 |
| Retroviral protease inhibiting compounds Grant 5,541,206 - Kempf , et al. July 30, 1 | 1996-07-30 |
| Retroviral protease inhibiting compounds Grant 5,461,067 - Norbeck , et al. October 24, 1 | 1995-10-24 |
| Retroviral protease inhibiting piperazine compounds Grant 5,455,351 - Kempf , et al. October 3, 1 | 1995-10-03 |
| Retroviral protease inhibiting compounds Grant 5,354,866 - Kempf , et al. October 11, 1 | 1994-10-11 |
| Retroviral protease inhibiting compounds Grant 5,151,438 - Sham , et al. September 29, 1 | 1992-09-29 |
| Heterocyclic renin inhibitors Grant 4,994,477 - Kempf , et al. February 19, 1 | 1991-02-19 |
| Angiotensinogen analogs Grant 4,857,507 - Rosenberg , et al. * August 15, 1 | 1989-08-15 |
| Peptidylaminodiols Grant 4,845,079 - Luly , et al. July 4, 1 | 1989-07-04 |
| Renin inhibiting compounds Grant 4,826,815 - Luly , et al. May 2, 1 | 1989-05-02 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 